Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05190211 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Primary and study completion dates: Dec 1, 2026 to Aug 1, 2026
    • Start date: Jan 1, 2022 to Nov 26, 2021
    • Site contact updated
    v7
  2. Notable Primary and study completion dates: Dec 1, 2024 to Dec 1, 2026v6
  3. Minor 2 versions Re-verified since Sep 27, 2023, no change to tracked fieldsv4-v5
  4. Notable Primary and study completion dates: Dec 1, 2022 to Dec 1, 2024v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 15, 2022 to Jan 1, 2022
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
It is to determine the effectiveness of different telerehabilitation exercise programs received to 2 groups randomly formed in idiopathic pulmonary fibrosis (IPF) patients. The cases meeting the inclusion criteria will be randomized and divided into two groups, the groups will be named as Telerehabilitation Exercise Group (TGr) and Video Group (VGr).
Trial Details
NCT Number NCT05190211
Lead Sponsor Istanbul Medipol University Hospital
Conditions
(from sponsor)
IPF
Related terms Motor Activity
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov